Status:
COMPLETED
DARE: Diabetes in cArdiac REhabilitation
Lead Sponsor:
Centre Hospitalier Universitaire Dijon
Conditions:
Type 2 Diabetes Mellitus
Coronary Artery Disease
Eligibility:
All Genders
25-95 years
Phase:
NA
Brief Summary
The aim of the DARE study is to see whether strict glycemic control during cardiac rehabilitation may ameliorate the improvement of exercise capacities (VO2 peak, peak workload, ventilatory threshold)...
Detailed Description
In a recent study, we showed that the benefit of cardiac rehabilitation on the improvement of exercise capacities (VO2 peak, peak workload, ventilatory threshold), after an acute coronary event, was s...
Eligibility Criteria
Inclusion
- Type 2 diabetes mellitus
- recent Miocardial Infarction
- HbA1c above 7%
- enrolled in a cardiac rehabilitation program
Exclusion
- Type 1 diabetes
- Coronary Bypass Surgery
- Renal Failure (creatinine clearance below 30 ml/min)
- severe Respiratory Failure
Key Trial Info
Start Date :
July 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2012
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00354237
Start Date
July 1 2005
End Date
December 1 2012
Last Update
November 18 2014
Active Locations (12)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre hospitalier du pays d'Aix
Aix-en-Provence, France, 13616
2
Clinique Rhône Durance
Avignon, France, 84082
3
Hôpital J Minjoz
Besançon, France, 25000
4
CMC Bligny
Briis-sous-Forges, France, 91640